ABCG2 and prostate cancer: Liu et al. have identified a prostate carcinoma-initiating stem-like cell subpopulation in the prostate cancer cell line 22Rv1 that is highly prolific, overexpresses ABCG2, and exhibits multidrug resistance [161].